Tissue Regenix reviewing its strategic options

Tissue Regenix Group PLC (AIM:TRX) has confirmed it is reviewing strategic options, which may include potential offers for the company. The firm has reached out to select parties to gauge interest but has not yet received any proposals. There is no certainty that any offers will be made, and the company advises shareholders to take no action for now. An "offer period" has commenced under the Takeover Code, but Tissue Regenix has been granted a dispensation allowing it not to disclose the identities of potential buyers unless they are named in rumours or speculation.